+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cancer Vaccines Market Analysis 2019

  • ID: 4857799
  • Report
  • October 2019
  • Region: Global
  • 145 pages
  • Syngene Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Aduro BioTech Inc
  • Bavarian Nordic
  • Dendreon
  • GlaxoSmithKline
  • Merck & Co Inc
  • PaxVax Corporation
  • MORE
The Global Cancer Vaccines market is growing at a CAGR of 18.7% from 2018 to 2026. Cancer vaccines are a kind of biological treatment that avoids and heals different sorts of cancer diseases, for example, cervical cancer, prostate cancer, lung cancer, breast cancer, and others. They are designed specifically to recognize and decrease the growth of cancer cells by the immune system. Besides, cancer vaccines are expected to decrease the prevalence and incidence rate of cancer. Factors for example, increasing occurrence of human papilloma virus (HPV) infections and high government investments for the advancement of these vaccines are driving the market growth. Though, longer time span required for manufacturing a single product and high cost for developing these vaccines are projected to inhibit the growth of the market.

By treatment method, preventive vaccine segment acquired significant growth in the market as they are the intended to prevent cancer in healthy people. These vaccines work by preventing infectious agents that cause or contribute to the development of cancer. Most of the preventive vaccines stimulate the production of antibodies, which bind to specific targeted microbes and block their ability to cause infection.

The key vendors mentioned are Aduro BioTech Inc, Astellas Pharma Inc, AstraZeneca PLC, Bavarian Nordic, Bharat Biotech, Bristol-Myers Squibb, Dendreon, Dynavax Technologies Corporation, Emergent Biosolutions, Galena Biopharma, Gamma Vaccines Pty Limited, GlaxoSmithKline, Gritstone Oncology, ImmunoBiology Ltd, Immunomic Therapeutics Inc, Merck & Co Inc, Novavax Inc, OSE Immunotherapeutics, PaxVax Corporation, Prokarium, Sanofi, Sinovac Biotech Ltd and VBI Vaccines Inc.

Treatment Methods Covered:
  • Therapeutic Vaccine
  • Preventive Vaccine
Technologies Covered:
  • Antigen/Adjuvant Cancer Vaccines
  • Dendritic Cells (DC) Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Viral Vector and DNA Cancer Vaccines
  • Whole Cell Cancer Vaccines
Types Covered:
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vector Vaccines
  • Subunit Vaccines
  • Viral Vector and DNA Vaccines
Applications Covered:
  • Breast cancer
  • Cervical Cancer
  • Lung cancer
  • Prostate Cancer
End Users Covered:
  • Adults
  • Pediatrics
Regions Covered:
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Key Questions Answered in this Report:
  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period

*Please Note: This report will be delivered within 48 hours of ordering.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aduro BioTech Inc
  • Bavarian Nordic
  • Dendreon
  • GlaxoSmithKline
  • Merck & Co Inc
  • PaxVax Corporation
  • MORE
1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Cancer Vaccines Market, By Treatment Method
5.1 Introduction
5.2 Therapeutic Vaccine
5.3 Preventive Vaccine

6 Global Cancer Vaccines Market, By Technology
6.1 Introduction
6.2 Antigen/Adjuvant Cancer Vaccines
6.3 Dendritic Cells (DC) Cancer Vaccines
6.4 Recombinant Cancer Vaccines
6.5 Viral Vector and DNA Cancer Vaccines
6.6 Whole Cell Cancer Vaccines

7 Global Cancer Vaccines Market, By Type
7.1 Introduction
7.2 Conjugate Vaccines
7.3 Inactivated Vaccines
7.4 Live Attenuated Vaccines
7.5 Recombinant Vector Vaccines
7.6 Subunit Vaccines
7.7 Viral Vector and DNA Vaccines

8 Global Cancer Vaccines Market, By Application
8.1 Introduction
8.2 Breast cancer
8.3 Cervical Cancer
8.4 Lung cancer
8.5 Prostate Cancer

9 Global Cancer Vaccines Market, By End User
9.1 Introduction
9.2 Adults
9.3 Pediatrics

10 Global Cancer Vaccines Market, By Geography
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 South America
10.5 Middle East & Africa

11 Strategic Benchmarking

12 Vendors Landscape
12.1 Aduro BioTech Inc
12.2 Astellas Pharma Inc
12.3 AstraZeneca PLC
12.4 Bavarian Nordic
12.5 Bharat Biotech
12.6 Bristol-Myers Squibb
12.7 Dendreon
12.8 Dynavax Technologies Corporation
12.9 Emergent Biosolutions
12.10 Galena Biopharma
12.11 Gamma Vaccines Pty Limited
12.12 GlaxoSmithKline
12.13 Gritstone Oncology
12.14 ImmunoBiology Ltd
12.15 Immunomic Therapeutics Inc
12.16 Merck & Co Inc
12.17 Novavax Inc
12.18 OSE Immunotherapeutics
12.19 PaxVax Corporation
12.20 Prokarium
12.21 Sanofi
12.22 Sinovac Biotech Ltd
12.23 VBI Vaccines Inc

List of Data Tables
Table 1 Global Cancer Vaccines Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Cancer Vaccines Market Outlook, By Treatment Method (2016-2026) ($MN)
Table 3 Global Cancer Vaccines Market Outlook, By Therapeutic Vaccine (2016-2026) ($MN)
Table 4 Global Cancer Vaccines Market Outlook, By Preventive Vaccine (2016-2026) ($MN)
Table 5 Global Cancer Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 6 Global Cancer Vaccines Market Outlook, By Antigen/Adjuvant Cancer Vaccines (2016-2026) ($MN)
Table 7 Global Cancer Vaccines Market Outlook, By Dendritic Cells (DC) Cancer Vaccines (2016-2026) ($MN)
Table 8 Global Cancer Vaccines Market Outlook, By Recombinant Cancer Vaccines (2016-2026) ($MN)
Table 9 Global Cancer Vaccines Market Outlook, By Viral Vector and DNA Cancer Vaccines (2016-2026) ($MN)
Table 10 Global Cancer Vaccines Market Outlook, By Whole Cell Cancer Vaccines (2016-2026) ($MN)
Table 11 Global Cancer Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 12 Global Cancer Vaccines Market Outlook, By Conjugate Vaccines (2016-2026) ($MN)
Table 13 Global Cancer Vaccines Market Outlook, By Inactivated Vaccines (2016-2026) ($MN)
Table 14 Global Cancer Vaccines Market Outlook, By Live Attenuated Vaccines (2016-2026) ($MN)
Table 15 Global Cancer Vaccines Market Outlook, By Recombinant Vector Vaccines (2016-2026) ($MN)
Table 16 Global Cancer Vaccines Market Outlook, By Subunit Vaccines (2016-2026) ($MN)
Table 17 Global Cancer Vaccines Market Outlook, By Viral Vector and DNA Vaccines (2016-2026) ($MN)
Table 18 Global Cancer Vaccines Market Outlook, By Application (2016-2026) ($MN)
Table 19 Global Cancer Vaccines Market Outlook, By Breast cancer (2016-2026) ($MN)
Table 20 Global Cancer Vaccines Market Outlook, By Cervical Cancer (2016-2026) ($MN)
Table 21 Global Cancer Vaccines Market Outlook, By Lung cancer (2016-2026) ($MN)
Table 22 Global Cancer Vaccines Market Outlook, By Prostate Cancer (2016-2026) ($MN)
Table 23 Global Cancer Vaccines Market Outlook, By End User (2016-2026) ($MN)
Table 24 Global Cancer Vaccines Market Outlook, By Adults (2016-2026) ($MN)
Table 25 Global Cancer Vaccines Market Outlook, By Pediatrics (2016-2026) ($MN)
Table 26 North America Cancer Vaccines Market Outlook, By Treatment Method (2016-2026) ($MN)
Table 27 North America Cancer Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 28 North America Cancer Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 29 North America Cancer Vaccines Market Outlook, By Application (2016-2026) ($MN)
Table 30 North America Cancer Vaccines Market Outlook, By End User (2016-2026) ($MN)
Table 31 Europe Cancer Vaccines Market Outlook, By Treatment Method (2016-2026) ($MN)
Table 32 Europe Cancer Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 33 Europe Cancer Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 34 Europe Cancer Vaccines Market Outlook, By Application (2016-2026) ($MN)
Table 35 Europe Cancer Vaccines Market Outlook, By End User (2016-2026) ($MN)
Table 36 Asia Pacific Cancer Vaccines Market Outlook, By Treatment Method (2016-2026) ($MN)
Table 37 Asia Pacific Cancer Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 38 Asia Pacific Cancer Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 39 Asia Pacific Cancer Vaccines Market Outlook, By Application (2016-2026) ($MN)
Table 40 Asia Pacific Cancer Vaccines Market Outlook, By End User (2016-2026) ($MN)
Table 41 South America Cancer Vaccines Market Outlook, By Treatment Method (2016-2026) ($MN)
Table 42 South America Cancer Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 43 South America Cancer Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 44 South America Cancer Vaccines Market Outlook, By Application (2016-2026) ($MN)
Table 45 South America Cancer Vaccines Market Outlook, By End User (2016-2026) ($MN)
Table 46 Middle East & Africa Cancer Vaccines Market Outlook, By Treatment Method (2016-2026) ($MN)
Table 47 Middle East & Africa Cancer Vaccines Market Outlook, By Technology (2016-2026) ($MN)
Table 48 Middle East & Africa Cancer Vaccines Market Outlook, By Type (2016-2026) ($MN)
Table 49 Middle East & Africa Cancer Vaccines Market Outlook, By Application (2016-2026) ($MN)
Table 50 Middle East & Africa Cancer Vaccines Market Outlook, By End User (2016-2026) ($MN)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Aduro BioTech Inc
  • Astellas Pharma Inc
  • AstraZeneca PLC
  • Bavarian Nordic
  • Bharat Biotech
  • Bristol-Myers Squibb
  • Dendreon
  • Dynavax Technologies Corporation
  • Emergent Biosolutions
  • Galena Biopharma
  • Gamma Vaccines Pty Limited
  • GlaxoSmithKline
  • Gritstone Oncology
  • ImmunoBiology Ltd
  • Immunomic Therapeutics Inc
  • Merck & Co Inc
  • Novavax Inc
  • OSE Immunotherapeutics
  • PaxVax Corporation
  • Prokarium
  • Sanofi
  • Sinovac Biotech Ltd
  • VBI Vaccines Inc
Note: Product cover images may vary from those shown
Adroll
adroll